Adipose tissue knockdown of lysozyme reduces local inflammation and improves adipogenesis in high-fat diet-fed mice. (April 2021)
- Record Type:
- Journal Article
- Title:
- Adipose tissue knockdown of lysozyme reduces local inflammation and improves adipogenesis in high-fat diet-fed mice. (April 2021)
- Main Title:
- Adipose tissue knockdown of lysozyme reduces local inflammation and improves adipogenesis in high-fat diet-fed mice
- Authors:
- Latorre, Jèssica
Lluch, Aina
Ortega, Francisco J.
Gavaldà-Navarro, Aleix
Comas, Ferran
Morón-Ros, Samantha
Rodríguez, Amaia
Becerril, Sara
Villarroya, Francesc
Frühbeck, Gema
Ricart, Wifredo
Giralt, Marta
Fernández-Real, José Manuel
Moreno-Navarrete, José María - Abstract:
- Abstract: Chronic systemic low-level inflammation in metabolic disease is known to affect adipose tissue biology. Lysozyme (LYZ) is a major innate immune protein but its role in adipose tissue has not been investigated. Here, we aimed to investigate LYZ in human and rodents fat depots, and its possible role in obesity-associated adipose tissue dysfunction. LYZ mRNA and protein were identified to be highly expressed in adipose tissue from subjects with obesity and linked to systemic chronic-low grade inflammation, adipose tissue inflammation and metabolic disturbances, including hyperglycemia, dyslipidemia and decreased markers of adipose tissue adipogenesis. These findings were confirmed in experimental models after a high-fat diet in mice and rats and also in o b/ob mice. Importantly, specific inguinal and perigonadal white adipose tissue lysozyme ( Lyz2 ) gene knockdown in high-fat diet-fed mice resulted in improved adipose tissue inflammation in parallel to reduced lysozyme activity. Of note, Lyz2 gene knockdown restored adipogenesis and reduced weight gain in this model. In conclusion, altogether these observations point to lysozyme as a new actor in obesity-associated adipose tissue dysfunction. The therapeutic targeting of lysozyme production might contribute to improve adipose tissue metabolic homeostasis. Graphical Abstract: ga1 Highlights: Lysozyme gene is highly expressed in human and mice subcutaneous and visceral adipose tissue in association to obesity. AdiposeAbstract: Chronic systemic low-level inflammation in metabolic disease is known to affect adipose tissue biology. Lysozyme (LYZ) is a major innate immune protein but its role in adipose tissue has not been investigated. Here, we aimed to investigate LYZ in human and rodents fat depots, and its possible role in obesity-associated adipose tissue dysfunction. LYZ mRNA and protein were identified to be highly expressed in adipose tissue from subjects with obesity and linked to systemic chronic-low grade inflammation, adipose tissue inflammation and metabolic disturbances, including hyperglycemia, dyslipidemia and decreased markers of adipose tissue adipogenesis. These findings were confirmed in experimental models after a high-fat diet in mice and rats and also in o b/ob mice. Importantly, specific inguinal and perigonadal white adipose tissue lysozyme ( Lyz2 ) gene knockdown in high-fat diet-fed mice resulted in improved adipose tissue inflammation in parallel to reduced lysozyme activity. Of note, Lyz2 gene knockdown restored adipogenesis and reduced weight gain in this model. In conclusion, altogether these observations point to lysozyme as a new actor in obesity-associated adipose tissue dysfunction. The therapeutic targeting of lysozyme production might contribute to improve adipose tissue metabolic homeostasis. Graphical Abstract: ga1 Highlights: Lysozyme gene is highly expressed in human and mice subcutaneous and visceral adipose tissue in association to obesity. Adipose tissue lysozyme expression is linked to adipose tissue inflammation and obesity-associated metabolic disturbances. Specific adipose tissue lysozyme gene knockdown reduces adipose tissue inflammation and restores adipogenesis. … (more)
- Is Part Of:
- Pharmacological research. Volume 166(2021)
- Journal:
- Pharmacological research
- Issue:
- Volume 166(2021)
- Issue Display:
- Volume 166, Issue 2021 (2021)
- Year:
- 2021
- Volume:
- 166
- Issue:
- 2021
- Issue Sort Value:
- 2021-0166-2021-0000
- Page Start:
- Page End:
- Publication Date:
- 2021-04
- Subjects:
- AT adipose tissue -- HFD high-fat diet -- HOMA-IR homeostasis model assessment-insulin resistance index -- iWAT Inguinal white adipose tissue -- KD knockdown -- LBP lipopolysaccharide-binding protein -- LPS: lipopolysaccharide -- LYZ human lysozyme gene -- Lyz2 mouse lysozyme gene -- NC negative control -- ND normal diet -- PBS phosphate-buffered saline -- pgWAT perigonadal white adipose tissue -- SAT subcutaneous adipose tissue -- SVF stromal vascular cell fraction -- T2D Type 2 diabetes -- TLR4 Toll-like receptor 4 -- VAT visceral adipose tissue
Adipogenesis -- Adipose tissue -- Gene knockdown -- Lysozyme -- Obesity
Pharmacology -- Periodicals
Pharmacology -- Periodicals
Research -- Periodicals
Médicaments -- Recherche -- Périodiques
Pharmacologie -- Périodiques
615.105 - Journal URLs:
- http://www.sciencedirect.com/science/journal/10436618 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.phrs.2021.105486 ↗
- Languages:
- English
- ISSNs:
- 1043-6618
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 6446.550000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 23027.xml